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Abstract
Eighty-one cocaine-dependent outpatients were assessed for their reactions to cocaine-related cues in a laboratory setting. All
subjects contributed a urine sample prior to the session. Compared with non-drug control cues, the cocaine stimuli produced
increases in physiological arousal, self-reports of high, craving, and withdrawal, and self-reports of negative mood. Subjects who
tested cocaine-positive on the day of testing differed only in skin resistance responding from those who tested cocaine-negative.
Changes in cue-induced physiological and self-report measures were also not associated with between-subject variations in mood
as measured by the Profile of Mood States (POMS) questionnaire administered prior to cue assessment. Thus, variations in
baseline mood and recent cocaine use history do not introduce an additional source of variability in cue reactivity measurements.
However, negative mood states at the start of a session were associated with higher levels of self-reported craving, high, and
withdrawal both before and after cue exposure. © 2000 Elsevier Science Ireland Ltd. All rights reserved.
Keywords: Cue reactivity; Cocaine dependence; Mood state; Craving; Cocaine use

1. Introduction
Many studies have demonstrated that cocaine-dependent individuals show alterations in mood, increases in
craving, and increases in physiological arousal when
presented with cocaine cues in the laboratory (Childress
et al., 1988; Ehrman et al., 1992; Berger et al., 1996;
Robbins et al., 1997; Reid et al., 1998). Such reactivity
is thought to provide some of the motivation to relapse
to cocaine use following treatment. As a result, many
laboratories have begun using measures of cue reactivity as outcome measures in trials of anti-craving medications (e.g. Kranzler and Bauer, 1992; Robbins et al.,
1992; Alim et al., 1994; Rosse, et al., 1994; Alim et al.,
1995; Satel et al., 1995; Berger, et al., 1996; Ehrman et
al., 1996). Such measurements are thought to have at
* Corresponding author. Present address: Department of Psychology, Beaver College, 450 S. Easton Road, Glenside, PA 19038, USA.
Tel.: + 1-215-5722987.
E-mail address: robbins@beaver.edu (S.J. Robbins)

least two advantages over traditional retrospective reports of cocaine craving.
First, retrospective reports require subjects to accurately estimate a subjective state that occurred hours or
days before the time of measurement. Such reports
obviously require that subjects be accurate and reasonably precise at recalling intensities of past internal
states. Unfortunately, two decades of memory research
has documented that recall, and particularly recall of
quantitative information, is often subject to reconstruction (e.g. Loftus, 1975) and to distortion by cognitive
shortcuts or heuristics (e.g. Tversky and Kahneman,
1973, 1974). Because cue reactivity studies require subjects to report on a state of craving as they currently
experience it, such biases are largely eliminated.
Second, retrospective craving reports may be influenced by idiosyncratic events or experiences occurring
during the days upon which the report is based. Subject
differences in history could include differential exposure
to real world drug cues, availability of money to buy
drugs, or various mood-altering experiences. Between

0376-8716/00/$ - see front matter © 2000 Elsevier Science Ireland Ltd. All rights reserved.
PII: S 0 3 7 6 - 8 7 1 6 ( 0 0 ) 0 0 1 0 3 - 9
This article is a U.S. government work, and is not subject to copyright in the United States.

34

S.J. Robbins et al. / Drug and Alcohol Dependence 59 (2000) 33–42

subject differences in such personal experiences may
obscure the effects of a subsequent treatment by introducing an uncontrolled source of within-group variability in the measurement of craving. Cue reactivity
studies reduce this problem by exposing all subjects to
a common set of drug-related events. This technique
not only reduces between-subject variance by examining craving under constant conditions, but also measures craving under the high-risk environment
conditions of most clinical concern.
Cue exposure measurements are not without disadvantages, however. The lack of drug availability in a
laboratory session may reduce craving levels, as might
the inability to adequately reproduce the full range of
real-world drug events. Furthermore, despite exposure
to a standardized set of laboratory cues, subjects may
be influenced by extra-session variables. In particular,
recent cocaine use and negative mood states at the time
of testing are two factors which have been shown
previously to influence self-reported craving. We will
review each of these factors in turn.
A number of studies have documented increases in
craving immediately following the administration of
cocaine in a laboratory setting (Jaffe et al., 1989; Fischman et al., 1990; Foltin and Fischman, 1997). Consequently, recent cocaine use may well lead to increases in
cue-induced craving as well. Cocaine use could affect
cue reactivity in other ways as well. If the patient is
under pressure from a treatment program to achieve
abstinence at the time of cue screening, then a recent
lapse could be especially distressing and lead to enhanced levels of cue-invoked anxiety or stress. Alternatively, recent drug use could reduce levels of cue
responding by satisfying an individual’s craving for the
drug. In any case, differences in recent drug use between individuals could confound the measurement of
treatment effects on cue reactivity.
Cue reactivity studies employing inpatients avoid the
potentially confounding influence of recent cocaine use.
However, studies often involve outpatient subjects who
continue to use cocaine throughout the trial. For example, Ehrman et al. (1998) found that 17 of 69 (25%)
outpatients enrolled in a study of ritanserin provided
cocaine-positive urine samples on the day of the laboratory cue session. Therefore, the influence of cocaine use
on reactivity represents a real concern in such studies.
Variations in general mood states may also serve to
modulate craving to laboratory cocaine cues. For example, Baker et al. (1987) proposed that craving may
result from either negative affect (withdrawal-based
urges) or from positive affect (incentive-based or appetitive urges). Many studies employing correlational designs have now documented that fluctuations in mood
states often covary with fluctuations in craving (e.g.
Sherman et al., 1986; Weddington et al., 1990; Satel et
al., 1991; Kowatch et al., 1992; Tunis et al., 1994; Covi

et al., 1995). Because correlational studies cannot be
used to draw the conclusion that negative mood states
cause craving, many investigators have used hypnosis
or short scripts to experimentally induce mood states.
For example, Tiffany and colleagues have shown that
short scripts with emotionally negative content can
produce craving in cigarette smokers (e.g. Tiffany and
Drobes, 1990; Maude-Griffin and Tiffany, 1996). Unfortunately, other studies have failed to confirm these
results (e.g. Drobes et al., 1994; Elash et al., 1995;
Droungas et al., 1995). Induced negative moods have
also produced craving in individuals who abuse heroin
and alcohol (Sherman et al., 1989; Litt et al., 1990;
Childress et al., 1994; Cooney et al., 1997).
The production of craving by experimentally-produced negative moods suggests that mood states may
influence the outcome of cue reactivity studies. Consequently, a number of studies have examined the joint
influence of drug cues and mood states on craving.
Unfortunately, the results of such studies have been
mixed (see Cooney et al., 1997 for a review). A number
of reports have found that negative moods enhance
cue-induced craving states (e.g. Greeley et al., 1992;
Elash et al., 1995; Maude-Griffin and Tiffany, 1996;
Cooney et al., 1997). However, other studies have failed
to obtain such effects (Litt et al., 1990; Tiffany and
Drobes, 1990; Childress et al., 1994; Shadel et al.,
1998). To our knowledge, no studies have yet examined
the influence of mood states on cocaine cue reactivity.
Given the widespread use of cue reactivity as a measurement tool in cocaine treatment studies, such investigations seem warranted.
In order to examine the impact of recent cocaine use
and mood on cue reactivity, we examined laboratory
responding in a sample of outpatient subjects who were
enrolled in a medication trial. All subjects were exposed
to the cues during a baseline session prior to the start of
medication. Subjects provided a urine sample on the
day of testing and completed the Profile of Mood States
questionnaire (POMS; McNair et al., 1971) prior to cue
exposure. Because subjects were participating in a
larger medication protocol, experimental manipulations
of mood state were not possible. Consequently, this
study employed a correlational design in which subject
variations in mood state and cocaine use prior to the
cocaine cue session were used as predictor variables and
cue-induced changes in physiological responding, selfreported moods, and self-reported drug states were
used as dependent measures.
The purpose of these analyses was to determine
whether levels of cue reactivity are associated with
baseline differences in mood state or drug use. If so,
then future studies would need to control for such
effects either by explicit experimental manipulations
(e.g. by employing inpatient rather than outpatient
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subjects or by inducing mood states) or by using covariance analyses incorporating the confounding factors.
The present study was also intended to address clinical
concerns that subjects who have recently used cocaine
or are in negative mood states might be at risk for
excessively high (clinically problematic) levels of craving in response to cocaine cues. If such a finding were
obtained, then additional exclusion criteria might be
required in future cue reactivity studies or in clinical
applications of cue exposure.

2. Methods

2.1. Research participants
The participants were 81 males who met DSM-III-R
criteria for cocaine dependence and were enrolled in
outpatient treatment at a Veterans Affairs Medical
Center. All subjects gave informed, voluntary consent
to participate in cocaine cue reactivity sessions. Subjects
also gave consent to participate in a medication study
of ritanserin, a 5-HT2 receptor antagonist (see Ehrman
et al., 1996). Demographic information on the subjects
was collected through use of an interview including the
Addiction Severity Index (ASI; McLellan et al., 1980)
conducted during treatment intake. Seventy-eight subjects were black, one was white, and two were Hispanic.
Subjects’ average age was 37.9 (S.D.=6.1) and they
had completed an average of 12.6 (S.D. = 1.4) years of
education. Subjects reported having used cocaine for
10.7 (S.D.=8.3) of the 30 days prior to the interview,
spending an average of US$ 544 (S.D.= 631) for drugs
during that month. They reported having used cocaine
regularly for an average of 6.3 (S.D.= 4.6) years prior
to treatment admission. Seventy-five subjects reported
that their usual route of administration was by smoking
crack cocaine; six subjects injected the drug intravenously. Reactivity data from a subset of these subjects were reported on in a previous paper describing
the effects of the medication ritanserin on cue reactivity
(Ehrman et al., 1996).

2.2. Procedures
2.2.1. Cue session procedures
All subjects participated in a cocaine cue session and
in two control cue sessions prior to the start of the
medication study. The sessions took place on separate
days within the same week. Time of day of the sessions
was not explicitly controlled but the order of session
presentations was balanced across subjects. One of the
control sessions consisted of a pilot test of cues intended to be physiologically arousing but non-drug
related. Data from that session are not included here.
The present paper presents findings from the cocaine
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cue session and from the control session employing a
standard set of non-drug control cues.
Upon arrival at the laboratory for the cue session,
participants were administered the POMS questionnaire
which requires rating the intensity of 65 mood-related
adjectives on a 0–4 scale. Item ratings are then combined into six summary scales or factor scores labeled
vigor, depression, tension, anger, fatigue, and confusion. The POMS has been used extensively to document
both the direct effects of cocaine administration (e.g.
Fischman et al., 1983a,b, 1985) and the effects of
cocaine abstinence (e.g. Weddington et al., 1990;
Kowatch et al., 1992; Rhoades et al., 1993; Tunis et al.,
1994; Covi et al., 1995; van Gorp et al., 1999). Subjects
were then asked to sit down in the sound-attenuated
recording chamber where surface recording electrodes
were attached and interfaced with a polygraph in an
adjacent control room.
Following electrode placement, subjects were asked
to rate the intensity of any feelings of cocaine-related
high, withdrawal, or craving. Answers were recorded
on a 0–10 scale with anchor points provided at 0 (‘not
at all’), 3 (‘mildly’), 7 (‘moderately’) and 10 (‘extremely’). Following these self-reports, physiological
recording was begun. During the initial baseline period
of 15 min, subjects sat quietly and no programmed
events were provided. Next, the subjects listened to an
audiotape for 10 min, watched a videotape for 10 min,
and performed a manual task for 5 min. Two-minute
rest intervals separated presentations of these events.
Following completion of physiological recording, subjects were again asked to rate their levels of high,
withdrawal, and craving and were readministered the
POMS. At the end of the cocaine cue session, subjects
were seen by an experienced therapist to discuss any
craving that may have persisted beyond cue presentations. Subjects met with the therapist until craving
levels had declined to pre-session levels. Counseling
sessions typically lasted no more than 15–20 min.

2.2.2. Content of the cocaine and non-drug cues
Stimuli presented during the cocaine cue session were
matched to each subject’s typical route of cocaine administration. Subjects who injected cocaine intravenously listened to an audiotape of patients discussing
cocaine injections, watched a videotaped simulation of
the preparation and insertion of a syringe, and prepared a syringe in the usual way during the task.
Syringe preparation involved the use of a lactose
solution.
For subjects who smoked cocaine, the audiotape
consisted of a discussion of the effects of smoking
cocaine. Two videotapes were available for these subjects. Patients who prepared their own cocaine crystals
(‘freebasers’) watched a video which depicted two individuals making freebase cocaine and then pretending to
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smoke the precipitate. Patients who bought already
packaged crystal cocaine (crack) watched a videotape in
which two individuals opened vials containing simulated
crack cocaine and pretended to smoke the crystals.
During the task, patients either performed a simulated
freebasing ritual involving benzocaine in the place of
cocaine, or handled crack vials filled with crystallized
benzocaine.
All subjects were exposed to the same set of stimuli
during the control session. The audiotape consisted of a
Wang word processing instructional tape, the video
consisted of an excerpt from a nature video, and the task
consisted of sorting a deck of Old Maid cards into
matching pairs.

2.2.3. Physiological recording procedures
Physiological recording was accomplished through the
use of Ag/AgCl surface recording electrodes interfaced
with a Grass model 7E polygraph located in a separate
control room. Two heart rate electrodes were employed,
one under the left clavicle and one under the lowest rib
on the subject’s left side. Skin resistance electrodes were
placed on the second phalanx of the index and middle
fingers of the non-dominant hand. The first phalanx of
the ring finger of the non-dominant hand served as the
site for the skin temperature electrode. Analog data from
the polygraph were amplified, converted to digital format, and stored on a computer for later analysis (see
Robbins et al., 1999 for more details and equipment
specifications).
2.2.4. Collection and analysis of urine samples
All subjects submitted a urine sample just prior to each
session. Analysis of the samples was performed using the
fluorescence polarization immunoassay technique, which
measures levels of the cocaine metabolite benzoylecgonine. Values greater than 300 ng/ml were classified as
cocaine positive. Past work has demonstrated that benzoylecgonine levels frequently remain detectable for three
or more days following cocaine use (Hawks and Chiang,
1986; Burke et al., 1990). Therefore, although a positive
test value indicates that cocaine use occurred at some
point in the few days prior to cue presentation, such a
value does not necessarily mean that the subject was
under the effects of cocaine at the time of the session.
Urine samples were also analyzed for the presence of
amphetamines, benzodiazepines, barbiturates, opiates,
cannabis, and methadone.

3. Results

3.1. General analytic plan
Three sets of analyses are presented below. First, we
compared responding between cocaine and non-drug

cues across all subjects. Those analyses involved two-way
repeated measures ANOVAs with session as one withinfactor and time (pre-post) as the second within-factor.
Evidence for response specificity to the cocaine cues
would come from session by time interactions in each
analysis. Levels of reactivity within each session were
then examined through paired t-tests comparing pre- and
post-cue responding. All these analyses employed a
significance threshold of a= 0.05.
The next two sets of analyses looked at the association
of recent drug use status and mood state with measures
of cue reactivity. Because the purpose of these analyses
was to establish whether reactions to cocaine cues are
modulated by mood state or drug use, only data from
the cocaine cue session were included.
The second set of analyses involve splitting subjects
into two groups: those who tested cocaine-positive prior
to the cocaine cue session and those who tested cocainenegative. Differences in reactivity between these groups
were analyzed by means of two-way ANOVAs in which
the group served as a between-factor and time (pre-post)
served as a within-factor. Changes in physiology, POMS
scores, and self-reported drug states during the cocaine
cue session served as dependent measures. An association
between prior cocaine use and levels of cue reactivity
would be revealed as a group by time interaction in each
analysis. Once again, all tests utilized a significance
threshold of a= 0.05 in order to maximize sensitivity to
possible group differences.
Finally, we examined whether cue reactivity was associated with variations in baseline mood. For these
analyses, we first calculated Pearson r correlations between each of the six POMS subscale scores collected at
baseline and cocaine cue-induced changes in physiology
and self-reported drug states (high, withdrawal, craving).
If more than one POMS score was significantly (P B
0.05) correlated with a given set of change scores, then
simultaneous multiple regression analyses were performed.
In all the analyses, physiological responding to the cues
was summarized as mean responding during the last 5
min of the video stimuli. Cue reactivity studies in our
laboratory have repeatedly obtained evidence that physiological arousal during drug cue sessions increases
across stimulus presentations, presumably because subjects become increasingly involved in imagining real drug
situations. For this reason, we have typically summarized
cue responding as mean responding during the last 10
min of the session (last 5 min of the video and last 5 min
of the task). In the present study, the card-sorting task
used in the non-drug session appeared to produce greater
motion artifact problems than seen with previous control
events. Consequently, physiological responding in this
study was summarized as mean responding over the last
5 min of the videotape. This period represented the last
portion of the session in which all subjects were exposed
to cocaine or control stimuli while completely at rest.
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Table 1
Physiological responding at baseline and the change produced by
video presentations during the cocaine and non-drug cue sessions a
Measure

Cocaine cue session

N

Skin temperature ( °F)
Baseline
77
93.1 (4.8)
Video change 77
−4.4 (3.6)
Skin resistance (kV)
Baseline
73
333.2 (199.3)
Video change 73 −54.0 (94.2)
Heart rate (beats/min)
Baseline
78
72.3 (9.3)
Video change 78
+1.6 (4.9)

Non-drug cue session

91.8 (6.2)
+0.1 (3.5)
318.0 (184.6)
+28.0 (56.5)
72.0 (9.0)
−2.0 (4.8)

a

Baseline physiology represents mean responding during the last 5
min of the baseline period. Video change scores were calculated by
subtracting the baseline value from mean responding during the last
5 min of the video. All values are means (S.D.). Sample sizes vary due
to missing data.

3.2. Comparing reacti6ity to cocaine and non-drug cues
3.2.1. Physiological responding
Reactions to the cues were summarized by subtracting
mean responding during the last 5 min of the baseline
period from mean responding during the last 5 min of
the video stimulus. Results for the two sessions are
depicted in Table 1. In order to compare responding
between the sessions, each physiological measure was
analyzed using a two-way repeated measures ANOVA
with session (cocaine cue vs. non-drug cue) as one
within-factor and time (baseline vs. video) as the second
within-factor. A separate analysis was run for each of the
three physiological measures. Each of the three session
by time interactions was significant (heart rate:
F(1, 77)=24.85,
P B0.001;
skin
temperature:
F(1, 76)=63.80, PB 0.001; skin resistance: F(1, 72)=
49.70, P B0.001).
Inspection of Table 1 reveals that the two sessions had
opposite effects on each of the physiological measures.
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Cue-induced changes were examined using paired t-tests
comparing response during the video and baseline periods. The cocaine video caused significant decreases in
skin temperature (t(76)= 10.76, PB 0.001) and skin
resistance (t(72)= 4.90, PB 0.001) and a significant
increase in heart rate (t(77)=2.90, PB 0.01). By contrast, the non-drug cues caused heart rate to decrease
(t(77)= 3.80, PB 0.001) and skin resistance to increase
(t(72)=4.23, PB 0.001). Skin temperature was not affected by the control cues. Thus, the cocaine cues caused
significant and specific increases in physiological arousal
across all three measures.

3.2.2. Self-reported mood states
Mood responding was summarized as the mean group
score for each of the six summary scales on the POMS.
Scores obtained before and after each session are shown
in Table 2. In order to compare reactivity during the two
sessions, the data were analyzed using a two-way repeated measures ANOVA with the session (cocaine or
non-drug) as one within-factor and time (pre- or postcues) as the other within-factor. Significant session by
time interactions were revealed for every POMS scale
except fatigue (anger: F(1, 75)= 8.75, PB 0.005; confusion: F(1, 74)= 10.21, PB 0.005; depression: F(1, 73)=
10.53, PB 0.005; tension: F(1, 71)= 27.49, PB0.001;
vigor: F(1, 72)=4.15, PB 0.05). Inspection of the means
in Table 2 reveals that these interactions all resulted from
the cocaine cues causing increases in negative mood
states, while the non-drug cues caused decreases or no
change at all.
Planned comparisons using paired t-tests were performed to compare post-cue with pre-cue response in
each session. As summarized in Table 2, the cocaine cues
produced significant increases in anger (t(75)=2.21,
PB 0.05), confusion (t(74)=3.23, PB0.01), depression
(t(73)= 2.80, PB 0.01), and tension (t(71)= 4.58, PB
0.001) and a significant decrease in vigor (t(72)=3.36,
PB 0.005). The non-drug cues actually produced minor

Table 2
Mean self-report scores on mood and drug state before and after exposure to the cocaine and non-drug cues a
N

Cocaine pre-cue

Cocaine post-cue

P

Non-drug pre-cue

Non-drug post-cue

P

POMS
Anger
Confusion
Depression
Fatigue
Tension
Vigor

76
75
74
76
72
73

5.0
4.4
8.8
3.1
5.9
17.7

6.2
5.4
10.4
3.3
9.4
16.1

0.03
0.002
0.007
NS
0.001
0.001

3.9
4.4
7.2
3.0
5.5
17.3

3.1
4.2
6.6
3.5
4.6
16.9

(6.3)
(3.5)
(8.4)
(4.4)
(3.4)
(7.0)

0.03
NS
NS
NS
0.002
NS

Drug state
Craving
High
Withdrawal

78
79
78

0.9 (1.6)
0.3 (1.1)
0.6 (1.6)

0.001
NS
0.054

(7.7)
(3.4)
(8.5)
(3.9)
(4.5)
(7.2)

2.1 (2.4)
0.4 (1.2)
1.0 (1.8)

(9.0)
(4.7)
(10.2)
(4.6)
(7.3)
(8.1)

4.6 (3.3)
2.1 (2.8)
2.0 (2.6)

0.001
0.001
0.001

(6.2)
(3.7)
(8.5)
(3.9)
(4.1)
(6.9)

1.9 (2.2)
0.3 (1.1)
0.9 (1.9)

a
All values are means (S.D.). Sample sizes vary due to missing data. P-values represent the results of paired t-tests comparing pre- and post-cue
means for each session. NS refers to P-values \0.05.

38

S.J. Robbins et al. / Drug and Alcohol Dependence 59 (2000) 33–42

changes in the opposite direction. Subjects showed significant decreases in anger (t(75) =2.23, P B 0.05) and
tension (t(71)=3.20, PB0.005) to the non-drug cues.
None of the other four scales showed significant changes
in response to the control stimuli. In sum, the cocaine
cues produced highly specific increases in negative mood
compared to control stimuli.

3.2.3. Self-reported drug states
Mean reported levels of craving, high, and withdrawal
before and after exposure to the two sets of cues are also
depicted in Table 2. Once again, differences in reactivity
to the two sets of cues were examined by means of a
two-way repeated measures ANOVA using session and
time as the two within-factors. Significant interactions
were revealed for all three drug self-reports (craving:
F(1, 77)=87.33, P B 0.001; high: F(1, 78) = 31.82, PB
0.001; withdrawal: F(1, 77) = 14.94, P B 0.001). Paired
t-tests comparing pre- and post-cue responding found
that the cocaine cues caused significant increases in
craving (t(77)=8.33, P B0.001), high (t(78) = 6.01, PB
0.001), and withdrawal (t(77) =3.69, P B0.001). The
non-drug cues caused a significant decrease in craving
(t(77)= 4.84, PB0.001), a decrease in withdrawal that
just missed the significance threshold (t(77) = 1.96, P=
.054), and no change in high.
3.3. Association of baseline cocaine use with le6els of
cue reacti6ity
Subjects were divided into two groups based on the
results of the urine test given on the day of the cocaine
cue session. Fifty subjects tested negative for cocaine
(group NEG) and 31 tested positive (group POS). Four
subjects in each of these groups also tested positive for
cannabis. In group NEG, one subject tested positive for
barbiturates and one tested positive for benzodiazepines.
No subjects in either group submitted urine samples
which revealed the use of amphetamines, opiates, or
methadone.

3.3.1. Physiological responding
Group differences in responding to the cocaine video
were examined by means of a two-way ANOVA with
group (POS or NEG) as the between factor and session
period (baseline vs. video) as the within factor. A separate
analysis was run for each of the three physiological
measures. The group by session interaction was significant only for the analysis of skin resistance; subjects in
group POS showed a greater drop in skin resistance than
subjects in group NEG (F(1, 74) =5.96, PB 0.05). In
group POS, mean skin resistance dropped from 469.3 kV
(S.D. =211.5) during baseline to 381.5 kV (S.D.= 189.9)
during the video. For group NEG, the baseline and video
scores were 261.8 (S.D. =144.2) and 226.5 (S.D. =
140.2), respectively. Paired t-tests revealed that both of

these declines were statistically significant (group POS:
t(26)= 5.00, PB 0.001; group NEG: t(48)= 2.79, PB
0.01).

3.3.2. Self-reported mood states
Between-group differences in POMS scores were examined using two-way, repeated measures ANOVAs
with group (POS or NEG) as the between factor and time
(pre- or post-session) as the within factor. Separate
analyses were performed for each of the six POMS
subscales. As described earlier, the cocaine cues generally
caused increases in negative mood states (see Table 2).
However, none of the group by time interactions were
significant, demonstrating that none of these changes in
negative mood differed across the groups.
3.3.3. Self-reported drug states
As described earlier, subjects showed significant increases in high, withdrawal, and craving in response to
the cocaine cues (see Table 2). However, two-way,
repeated measures ANOVAs revealed no group by time
interactions. Thus, increases in self-reported drug states
did not differ between subjects who tested positive or
negative for cocaine at the time of cue exposure.
3.4. Association of baseline mood with le6els of cue
reacti6ity
In order to examine the association between baseline
mood and cue reactivity, we first calculated Pearson r
correlations between each of the six POMS scores and
the physiological and drug state change scores produced
in response to the cocaine cues. Thus, there were a total
of 36 correlations (six POMS scores× six dependent
measures). Of these correlations, only three reached
statistical significance. Cue-induced changes in self-reported craving were significantly correlated with pre-cue
levels of vigor (r= − 0.23, P= 0.043), depression (r=
0.23, P= 0.043), and fatigue (r= 0.27, P = 0.016). If a
more conservative alpha value of 0.01 or below is used
to correct for the multiple tests, then none of the
correlations would have reached significance.
In order to explore the correlations with craving
further, we performed a simultaneous multiple regression
analysis using vigor, depression, and fatigue scores as the
predictor variables and craving change score as the
dependent variable. The resulting model produced an
overall F statistic of 2.62 (P= 0.057), a multiple r value
of 0.312, and an r 2 value of 0.097. None of the three
predictor variables contributed a statistically significant
amount of variance to the model (all P values \0.20).
Finally, we calculated Pearson r correlations between
scores on each of the baseline POMS subscales and
reports of high, withdrawal, and craving before and after
the session. Those correlations are shown in Table 3. As
seen in the table, 30 of the 36 correlations are significant
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Table 3
Correlations between scores on each of the precue POMS subscales and reports of high, withdrawal, and craving before and after cue exposure a
Craving

Anger
Confusion
Depression
Fatigue
Tension
Vigor

High

Withdrawal

Pre-cue

Post-cue

Pre-cue

Post-cue

Pre-cue

Post-cue

0.33 **
0.29 **
0.41 **
0.23 *
0.33 **
−0.28 *

0.25 *
0.32 **
0.44 **
0.36 **
0.28 *
−0.31 **

0.29 *
0.44 **
0.43 **
0.38 **
0.27 *
−0.20

0.12
0.34 **
0.27 *
0.21
0.29 *
−0.12

0.33 **
0.33 **
0.40 **
0.23 *
0.36 **
−0.23 *

0.11
0.26 *
0.29 *
0.24 *
0.26 *
−0.17

a

Shown are Pearson r values.
* PB0.05.
** PB0.01.

at the 0.05 level. The five negative mood states (anger,
confusion, depression, fatigue, and tension) were positively correlated with all three drug states while the vigor
subscale showed negative correlations with the drug-related self-reports. Thus, subjects who reported higher
levels of craving, high, and withdrawal both before and
after the cue session also reported more negative mood
states before the session.

4. Discussion
Subjects in this study showed significant increases in
arousal, self-reported drug states, and self-reported negative mood following exposure to laboratory cocaine
cues. The cocaine cue responses were similar in form and
magnitude to those recorded in past studies in our
laboratory (e.g. Ehrman et al., 1992; Robbins et al., 1992,
1999) and differed in both form and magnitude from
reactivity produced by non-drug control events. However, variations in reactivity to the cocaine cues were
generally not associated with between-subject differences
in recent cocaine use and mood state prior to the session.
Subjects who provided a cocaine-positive urine sample
on the day of cue assessment did not differ on 11 of 12
cue reactivity measures from subjects who tested cocainenegative. The two groups did not show different cue-elicited changes in any of the six POMS scores, in reports
of high, withdrawal, and craving, or in heart rate and skin
temperature change scores. Subjects in group POS did
show a greater drop in skin resistance than subjects in
group NEG. However, subjects in group POS also had
baseline skin resistance scores that were nearly double
those of group NEG. Thus, it is unclear whether this
single difference between groups reflects a true association between cocaine use and cue reactivity, an artifact
of a highly elevated baseline, or an instance of type 1
error. In any case, the negative results on 11 of 12
measures suggest that cocaine use prior to a cue reactivity
session has at best only a minimal relationship to
cue-elicited responding.

The present study also failed to uncover significant
associations between baseline POMS scores and cue
reactivity. Of 36 correlations between the six POMS
scores and the six cue reactivity measures, only three were
significant at the 0.05 level (vigor, depression, and fatigue
were correlated with cue-elicited craving). Given the 0.05
significance level used, two of the correlations would be
expected to reach significance by type 1 error alone. Had
a more conservative 0.01 significance level been employed, none of the correlations would have reached
significance. Furthermore, a multiple regression analysis
using the vigor, fatigue, and depression scores as predictors failed to account for a significant proportion of the
variance in craving.
The present results indicate that laboratory measures
of cocaine cue reactivity are not significantly associated
with temporally contiguous external events such as
normal variations in subject mood or recent cocaine use.
Thus, laboratory measures of cue-induced craving serve
to eliminate many sources of uncontrolled variance
which otherwise might influence subject self-reports. By
reducing sources of variability across subjects within a
commonly treated group, cue exposure sessions provide
a more powerful assessment of potential differences
between groups in treatment studies.
Several limitations of the present data are important
to note. First, although the presence of a cocaine-positive
urine sample on the day of cue assessment demon-strates
that a subject has used cocaine sometime in the few days
prior to testing, the urine result cannot be used to
determine whether the subject is actually experiencing
drug effects (such as intoxication or withdrawal) at the
time of testing. Thus, the present results do not rule out
the possibility that drug use occurring immediately
before testing may affect a subject’s responses. In our
studies, laboratory technicians are instructed to exclude
subjects from testing if they appear to be under the
influence of drugs at the start of a session. Thus, it is
unlikely that any of the subjects were actually in a
drug-induced state at the time of testing (in fact, no
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participants appeared to be intoxicated at the time of
testing). As noted earlier, previous laboratory studies
have shown that craving does increase immediately
following cocaine use (Jaffe et al., 1989; Fischman et
al., 1990; Foltin and Fischman, 1997). Thus, we would
continue to recommend excluding subjects from cue
exposure who appear to be under the influence of drugs
at the time of testing.
A second limitation concerns the range of mood
states reported by patients on the POMS questionnaire.
In general, the mean subscale scores recorded here were
similar to those reported in other treatment studies of
cocaine-dependent individuals (e.g. Weddington et al.,
1990; Covi et al., 1995; van Gorp et al., 1999) but much
less extreme than those produced by psychiatrically-impaired groups of individuals in the original validation
studies of the POMS questionnaire (McNair et al.,
1971). Thus, the present data do not address whether
more extreme mood scores might influence cue responding. Furthermore, because the present study employed only a single cue reactivity session, the results
cannot be used to conclude that within-subject variations in mood state are unrelated to cue-induced craving and physiological arousal. Different individuals
may be particularly susceptible to cocaine cues in the
presence of different mood states. In that case, variations in a particular mood state may lead to variations
in cue responding for some subjects but not for others.
Although the present study demonstrates that betweensubject variations in mood are unrelated to cue responding, these results do not address the effects of
within-subject variations.
Although the limited range of baseline moods measured in this study place limits on its generalizability to
more psychiatrically-impaired populations, it is important to remember that the individuals studied here
represent a typical group of cocaine abuse patients seen
in our outpatient cocaine treatment center. Thus, the
results do demonstrate that the typical range of moods
displayed by our usual sample of largely male,
African–American, lower SES patients are not associated with variations in cue reactivity. The external
validity of this finding should be no less than the
external validity of any other results produced with
such a sample. Furthermore, the average POMS scores
recorded in this study were quite similar to those
recorded in earlier studies with cocaine-dependent patients (e.g. Weddington et al., 1990; Covi et al., 1995;
van Gorp et al., 1999). Consequently, there is little
reason to believe that the range of POMS scores
recorded in this study were substantially lower than
those typically obtained from cocaine-dependent
outpatients.
A third limitation in this study concerns the use of
single-item scales to measure high, withdrawal, and
craving. Some authors have argued that single-item

scales are inadequate to capture the multifaceted nature
of subjective states such as craving (e.g. Tiffany et al.,
1993). As an alternative, Tiffany et al. (1993) proposed
that craving studies utilize a 45-item cocaine craving
questionaire (CCQ) which identifies separate dimensions of the craving state. Although the three drug state
questions used here do not capture the multidimensional nature of subjective drug effects, they do have
several virtues in their favor. First, cocaine dependent
patients provide significantly different scores on these
items when faced with cocaine versus non-cocaine cues
(Ehrman et al., 1992; Table 2 of the present paper).
Second, non-drug users provide lower reports on these
scales in response to cocaine cues than do cocaine
dependent outpatients (Ehrman et al., 1992). Finally,
previous work in our laboratory has shown that an
increase across single-item craving scores collected three
days apart predicts an increased likelihood of cocaine
use during that 3-day period (Robbins and Ehrman,
1998). To our knowledge, the CCQ has not been similarly validated against the results of repeated urine
tests.
A final limitation of these results involves the lack of
information on pre-session caffeine or nicotine use. In
principle, variations across participants in use of these
stimulants could produce an additional source of variability in baseline physiology or in physiological responses to the cues. Such variability could have reduced
the power of the present analyses to detect relationships
between pre-cue variables and cue reactivity. Some
evidence for the interaction of nicotine use with cocaine
cue reactivity comes from a recent study by Reid et al.
(1998). They found that pre-cue nicotine use enhanced
craving produced by the cocaine cues but had no effect
on skin temperature or skin conductance responding.
This effect of nicotine on craving suggests that future
studies further explore the potential impact of nicotine
and caffeine on cocaine cue reactivity.
Despite the lack of a relationship between baseline
mood states and physiological or subjective cue reactivity, there was strong evidence that mood states were
associated with the magnitude of drug-related feelings
experienced prior to and following cue exposure. In
general, subjects who reported higher levels of negative
mood also reported higher levels of cocaine craving,
high, and withdrawal. As discussed in Section 1, these
results are consistent with a number of earlier correlational studies (e.g. Sherman et al., 1986; Weddington et
al., 1990; Satel et al., 1991; Kowatch et al., 1992; Tunis
et al., 1994; Covi et al., 1995).
These correlations between drug states and negative
mood could be interpreted in several ways. First, the
correlations could indicate that subjects in treatment
feel badly when experiencing forbidden drug-related
feelings. In other words, craving, high, and withdrawalcould have been the cause of the negative emotions
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reported on the POMS. Second, negative moods
might be a cause of drug craving and associated feelings of high and withdrawal (see Baker et al., 1987).
Earlier work (Sherman et al., 1989; Litt et al., 1990;
Tiffany and Drobes, 1990; Childress et al., 1994;
Maude-Griffin and Tiffany, 1996; Cooney et al.,
1997) has demonstrated that induced negative moods
can increase craving for cigarettes, opiates, and alcohol. In a similar way, negative moods reported by
subjects in the current study might serve as cues
which produce craving and other drug states. Finally,
the negative mood states experienced by patients
might reflect the same emotional states being labeled
as craving, withdrawal, and high. Patients may be less
capable of discriminating different internal states than
we think and may apply the whole range of available
mood labels to a single set of feelings. Because the
present study was not designed to experimentally manipulate mood states, these alternatives cannot be disentangled.
If we assume that mood states are the cause of the
associated drug states experienced prior to the session, then craving caused by drug cues appears to be
an independent source of drug craving. Although
moods were well-correlated with craving experienced
both before and after the session, they were not significantly associated with the magnitude of craving
change experienced during cue presentations. Therefore, negative mood states and drug cues could be
thought of as separate sources of craving whose effects summate to determine an individual’s overall
level of drug desire (see Cooney et al., 1997). In that
case, future behavioral treatments could be aimed at
reducing craving caused both by drug-related cues
and negative mood states. Furthermore, putative anticraving medications could be examined for their effects on craving resulting from each source. However,
such conclusions await the results of studies employing experimental manipulations of mood states with
cocaine abuse patients.
In sum, the present study demonstrates that reactions to cocaine cues in the laboratory are largely
independent of between-subject variations in mood
state and recent cocaine use. Although previous studies have shown that these variables can influence drug
craving, the present results provided no evidence for
such an association with craving responses to laboratory cocaine cues. These findings support one of the
basic assumptions behind the use of cue reactivity
assessments as measures of treatment progress,
namely that such sessions reduce within-group variability in craving reports. By reducing at least two
uncontrolled sources of variance in craving measurements, cue reactivity sessions increase the power of
treatment studies to detect between-group differences
in craving.
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